US Stocks
/
Galectin Therapeutics Inc. Share Price
Galectin Therapeutics Inc. Share Price

Galectin Therapeutics Inc. Share Price

NASDAQ: GALT | Micro Cap
$3.81
+$0.18 (4.97%) Last updated on 09 Oct, 2026 | 22:14 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Galectin Therapeutics Inc. Stock Performance

Open
$3.72
Prev. Close
$3.63
Circuit Range
N/A
Day Range
$3.69 - $3.77
Year Range
$2.02 - $7.13
Volume
2,572
Average Traded
$3.73

Galectin Therapeutics Inc. Share Price Today

As of 9 October 2026, Galectin Therapeutics Inc.'s share price is $3.81. The stock opened at $3.72, compared to its previous close of $3.63. During today's trading session, Galectin Therapeutics Inc.'s share price traded between $3.69 and $3.77, with an average price of $3.73. Over the past 52 weeks, the stock has recorded a high of $7.13 and a low of $2.02. In terms of performance, Galectin Therapeutics Inc.'s share price has risen by 68.36% over the last six months and is down 34.40% on a year-on-year basis.

Galectin Therapeutics Inc. Share Price Chart

$3.69$3.77
L
Show Current Price
H

Galectin Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$243.15M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.28
Revenue (TTM)
$0.00
Return On Equity (TTM)
20.23%
Profit Margin
N/A
Debt to Equity
-0.24
Quarterly Earnings Growth YoY
-11.68%

Galectin Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.22-$5.56-$5.07-$9.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A32.36%8.81%-81.07%

Galectin Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.87-$44.81-$47.20-$30.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-15.28%-5.33%34.39%

About Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Galectin Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.94
$3.75
-3.85%
Sep 2026
$4.03
$3.90
-5.91%
Aug 2026
$3.05
$4.14
+39.80%
Jul 2026
$4.61
$2.96
-35.96%
Jun 2026
$2.52
$4.63
+83.73%
May 2026
$2.25
$2.52
+11.50%
Apr 2026
$2.84
$2.26
-19.00%
Mar 2026
$3.06
$2.79
-6.22%
Feb 2026
$2.90
$2.98
+5.12%
Jan 2026
$4.22
$2.83
-31.81%
Dec 2025
$5.71
$4.15
-27.19%
Nov 2025
$5.71
$5.70
-1.72%

GALT Share Price FAQs

What is Galectin Therapeutics Inc. share price today?

chevron-up
Galectin Therapeutics Inc. share price today is $3.81 as on October 9, 2026 at 10:14 pm IST.

What is the 52 week high and 52 week low of Galectin Therapeutics Inc. stock?

chevron-up
The 52 week high of Galectin Therapeutics Inc. stock is $7.13, while the 52 week low is $2.02 as of 9 Oct '26.

What is GALT's market capitalisation today?

chevron-up
GALT market capitalisation is $243.15M as of October 9, 2026, at 10:17 pm IST.

What is GALT's net income for the last quarter?

chevron-up
GALT's net income for the last quarter is -9.18B USD.

What is the 5 year returns of GALT?

chevron-up
The 5 year returns of GALT is 20.03% as on 9 Oct '26.

What is the high & low stock price of GALT today?

chevron-up
GALT stock price hit a high of $3.77 and low of $3.69 as of 9 Oct '26.

Can I buy GALT shares in India?

chevron-up
Yes. You can buy GALT in India by opening an international trading account.